ZA92913B - New beta-amino-alpha hydroxycarboxylic acids and ttheir use - Google Patents

New beta-amino-alpha hydroxycarboxylic acids and ttheir use

Info

Publication number
ZA92913B
ZA92913B ZA92913A ZA92913A ZA92913B ZA 92913 B ZA92913 B ZA 92913B ZA 92913 A ZA92913 A ZA 92913A ZA 92913 A ZA92913 A ZA 92913A ZA 92913 B ZA92913 B ZA 92913B
Authority
ZA
South Africa
Prior art keywords
ttheir
amino
hydroxycarboxylic acids
new beta
alpha hydroxycarboxylic
Prior art date
Application number
ZA92913A
Other languages
English (en)
Inventor
Yichiro Yabe
Susumu Higashida
Takashi Nishigaki
Mitsuya Sakurai
Tomoaki Komai
Hiroshi Handa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ZA92913B publication Critical patent/ZA92913B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA92913A 1991-02-08 1992-02-07 New beta-amino-alpha hydroxycarboxylic acids and ttheir use ZA92913B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1734191 1991-02-08

Publications (1)

Publication Number Publication Date
ZA92913B true ZA92913B (en) 1993-05-06

Family

ID=11941358

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92913A ZA92913B (en) 1991-02-08 1992-02-07 New beta-amino-alpha hydroxycarboxylic acids and ttheir use

Country Status (12)

Country Link
EP (1) EP0498680A1 (fr)
KR (1) KR920016417A (fr)
CN (1) CN1039321C (fr)
AU (1) AU647239B2 (fr)
CA (1) CA2060844A1 (fr)
CS (1) CS35692A3 (fr)
HU (2) HUT60282A (fr)
IE (1) IE920414A1 (fr)
IL (1) IL100899A (fr)
RU (1) RU2120447C1 (fr)
TW (1) TW304197B (fr)
ZA (1) ZA92913B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313094B1 (en) 1990-12-11 2001-11-06 Japan Energy Corporation β-amino-α-hydroxycarboxylic acid derivatives and HIV protease inhibitors
AU3278293A (en) * 1991-12-20 1993-07-28 Syntex (U.S.A.) Inc. Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
EP0633881B1 (fr) * 1992-03-11 2003-10-29 Narhex Limited Derives amines d'hydrocarbures a substitution oxo et hydroxy
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
EP0574135B1 (fr) * 1992-05-13 1998-11-18 Japan Energy Corporation Procédé de préparation de dérivés peptidiques et leurs corps salins
US5644028A (en) * 1992-05-13 1997-07-01 Japan Energy Corporation Process for producing peptide derivatives and salts therefor
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
ZA935697B (en) * 1992-08-07 1994-03-10 Sankyo Co Peptides capable of inhibiting the activity of hiv protease their preparation and their therapeutic use
US5846993A (en) * 1992-12-22 1998-12-08 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5733906A (en) * 1993-10-12 1998-03-31 Eli Lilly And Company Inhibitors of HIV Protease useful for the treatment of Aids
IL110898A0 (en) * 1993-09-10 1994-11-28 Narhex Australia Pty Ltd Polar-substituted hydrocarbons
DK0746320T3 (da) * 1994-02-02 2001-02-19 Lilly Co Eli HIV-proteaseinhibitorer og mellemprodukter
US5480887A (en) * 1994-02-02 1996-01-02 Eli Lilly And Company Protease inhibitors
US5527829A (en) * 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
DE69524527D1 (de) * 1994-10-14 2002-01-24 Japan Energy Corp AIDS-hemmende Arzneizubereitung und Verfahren
CA2179935C (fr) * 1995-06-30 2010-09-07 Ryohei Kato Compose dipeptidique ou sel de ce dernier acceptable en pharmacie; utilisation en medecine
US6222043B1 (en) 1995-06-30 2001-04-24 Japan Energy Corporation Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5705647A (en) * 1996-09-05 1998-01-06 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
CA2249747A1 (fr) 1996-12-27 1998-07-09 Tsutomu Mimoto Nouveaux composes de tripeptides et medicaments anti-sida
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
CA2253629A1 (fr) 1997-03-14 1998-09-24 Snow Brand Milk Products Co., Ltd. Agent preventif et/ou curatif de la cachexie
US6084107A (en) * 1997-09-05 2000-07-04 Agouron Pharmaceuticals, Inc. Intermediates for making HIV-protease inhibitors
US6403818B1 (en) 2000-02-28 2002-06-11 Eisai Co., Ltd. Process for producing α-hydroxy-carbonyl compound
US7704957B2 (en) 2001-04-09 2010-04-27 Rural Development Administration Composition for inhibiting HIV activity extracted from Paecilomyces sp. (Tochu-kaso) J300
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
EP1702916A1 (fr) * 2005-03-18 2006-09-20 Santhera Pharmaceuticals (Schweiz) GmbH Inhibiteurs de DPP-IV
GB0914574D0 (en) * 2009-08-20 2009-09-30 Givaudan Sa Organic compounds
KR102475443B1 (ko) 2020-11-06 2022-12-08 함상덕 자동 필터 먼지제거장치
US11814367B2 (en) 2021-03-15 2023-11-14 Maze Therapeutics, Inc. Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182110A (fr) * 1980-07-10 1985-02-05 Hamao Umezawa Tetrapeptides a action physiologique
CA1340588C (fr) * 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides

Also Published As

Publication number Publication date
AU1081292A (en) 1992-08-13
HU211834A9 (en) 1995-12-28
CN1064683A (zh) 1992-09-23
IL100899A0 (en) 1992-11-15
AU647239B2 (en) 1994-03-17
CN1039321C (zh) 1998-07-29
HU9200392D0 (en) 1992-04-28
HUT60282A (en) 1992-08-28
CS35692A3 (en) 1992-09-16
KR920016417A (ko) 1992-09-24
IL100899A (en) 1997-06-10
TW304197B (fr) 1997-05-01
RU2120447C1 (ru) 1998-10-20
CA2060844A1 (fr) 1992-08-09
IE920414A1 (en) 1992-08-12
EP0498680A1 (fr) 1992-08-12

Similar Documents

Publication Publication Date Title
ZA92913B (en) New beta-amino-alpha hydroxycarboxylic acids and ttheir use
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
GB9121289D0 (en) Composition and use
PL294883A1 (en) New contenerization methods and aqueous mixtures
IL102813A0 (en) Imidazolyl-alkenoic acids
IL101038A0 (en) Agent specific for trombin and its use
ZA929127B (en) Quinoline-3-carboxamides their manufacture and use
ZA921279B (en) Substituted alpha-aminoaldehydes and derivatives
ZA929128B (en) Hydroxypyridonecarboxamides their manufacture and use
PH30097A (en) Aminoalkanephosphini acids and salts thereof
YU102589A (en) Compound and use thereof
GB9203517D0 (en) Composition and use
EP0456138A3 (en) Peptide-amidase and its application
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
GB8901996D0 (en) Compounds and use
GB9314512D0 (en) Composition and use
AU5656994A (en) Chiral arylpropionates and their use
EP0505941A3 (en) Peptifluorin and neopeptifluorin
AR245119A1 (es) Procedimiento para preparar un grupo de fenilalquiltiofenos que estan sustituidos adicionalmente con un grupo acido tiadicarboxilico.
ZA925237B (en) Substituted 1-phenyl-1-benzoylamino-5-aminopentanes their preparation and use
GB9114574D0 (en) Compound and use
IE893645L (en) Naphthalene derivatives and fluoroalkanoic acids and their¹esters
GB8909864D0 (en) Nematotoxic compounds and their use
GB8907953D0 (en) Nematotoxic compounds and their use
GB8929025D0 (en) Compound and use